TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Karlskoga Bio AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 367 | 283 | 197 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | 78 | 80 | 9 |
EBITDA | 82 | 81 | 15 |
Total assets | 184 | 207 | 140 |
Current assets | 160 | 207 | 138 |
Current liabilities | 74 | 123 | 116 |
Equity capital | 111 | 85 | 24 |
- share capital | 9 | 9 | 10 |
Employees (average) | 3 | 3 | 4 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 60.3% | 41.1% | 17.1% |
Turnover per employee | 122 | 94 | 49 |
Profit as a percentage of turnover | 21.3% | 28.3% | 4.6% |
Return on assets (ROA) | 42.4% | 38.6% | 6.4% |
Current ratio | 216.2% | 168.3% | 119.0% |
Return on equity (ROE) | 70.3% | 94.1% | 37.5% |
Change turnover | 83 | 102 | 39 |
Change turnover % | 29% | 57% | 25% |
Chg. No. of employees | 0 | -1 | 0 |
Chg. No. of employees % | 0% | -25% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.